PARIS: An anti-COVID drug widely used across the world may have caused mutations in the virus, researchers said on Monday (Sep 25), but there was no evidence that the changes had led to more dangerous variants. Pharmaceutical giant Merck's antiviral pill molnupiravir was one of the earliest treatments